Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Englund

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Pediatrics|January 5, 2000
Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccinesM B Rennels, M A Deloria, M E Pichichero, et al.
Pediatrics|September 2, 1999
Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study TeamC Raskino, D A Pearson, C J Baker, et al.
Pediatrics|January 5, 2000
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old childrenM E Pichichero, K M Edwards, E L Anderson, et al.
The Journal of Infectious Diseases|September 30, 2000
Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected childrenJ C Lindsey, M D Hughes, R E McKinney, et al.
Epidemiology and Infection|October 15, 2019
Risk factors and patterns of household clusters of respiratory viruses in rural NepalE M Scott, A Magaret, J Kuypers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adultsJ A Englund, R E Champlin, P R Wyde, et al.
Bone Marrow Transplantation|September 1, 1995
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipientsE Whimbey, R E Champlin, J A Englund, et al.
Pediatrics|September 1, 1995
The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoidsJ A Englund, E L Anderson, G F Reed, et al.
Pediatrics|November 14, 1997
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old childrenM E Pichichero, M A Deloria, M B Rennels, et al.
Pediatrics|September 1, 1995
Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccinesM B Rennels, G F Reed, M D Decker, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Pediatrics|January 5, 2000
Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccinesM B Rennels, M A Deloria, M E Pichichero, et al.
Pediatrics|September 2, 1999
Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study TeamC Raskino, D A Pearson, C J Baker, et al.
Pediatrics|January 5, 2000
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old childrenM E Pichichero, K M Edwards, E L Anderson, et al.
The Journal of Infectious Diseases|September 30, 2000
Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected childrenJ C Lindsey, M D Hughes, R E McKinney, et al.
Epidemiology and Infection|October 15, 2019
Risk factors and patterns of household clusters of respiratory viruses in rural NepalE M Scott, A Magaret, J Kuypers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adultsJ A Englund, R E Champlin, P R Wyde, et al.
Bone Marrow Transplantation|September 1, 1995
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipientsE Whimbey, R E Champlin, J A Englund, et al.
Pediatrics|September 1, 1995
The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoidsJ A Englund, E L Anderson, G F Reed, et al.
Pediatrics|November 14, 1997
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old childrenM E Pichichero, M A Deloria, M B Rennels, et al.
Pediatrics|September 1, 1995
Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccinesM B Rennels, G F Reed, M D Decker, et al.
Pageof 9